UNSPSC 51162645: Normethadone

This classification denotes an opioid receptor agonist with the molecular formula C20H25NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) KR2L2A68XL, chemically known as 6-dimethylamino-4,4-diphenyl-3-hexanone but more generally known as normethadone, which bears US NIH Compound Identifier 10090. European Medicines Agency schedules Normethadone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09376MIG. The term NORMETHADONE is an International Non-Proprietary Name.

UNSPSC 51162645 Normethadone is a Commodity code that in recent state and local activity covers pharmaceutical procurement, though the posted opportunities show minimal direct demand for normethadone itself and instead reflect broader pharmaceutical and opioid-response product sourcing. Seminole County, Florida and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued solicitations in 2026 requesting pharmaceuticals and related products, but neither opportunity explicitly names normethadone as a required item. The Seminole County solicitation (IFB 60459723LAS, posted June 2026) seeks naloxone and drug deactivation systems for community health initiatives, while the MMCAP RFP (S1070000015802, posted January 2026) establishes master contracts for generic multi-source pharmaceuticals and OTC products distributed to state and local facilities across participating jurisdictions including Minnesota and Oregon. State and local purchasing under this code appears driven by counties and cooperative purchasing alliances rather than individual cities or school districts, with a focus on pharmaceutical supply agreements that serve public health and community safety missions.

Geographically, recent activity centers on Florida and the Upper Midwest (Minnesota and Oregon), though MMCAP's multi-state cooperative structure means participating jurisdictions across the country may access established contracts. Seminole County's IFB closes July 26, 2023 (note: this date appears inconsistent with the June 2026 posting and may reflect a data error in the source), with responses due electronically through the county's e-Procurement Portal; the contract term runs two years with a one-year renewal option. The MMCAP RFP closed March 26, 2026, with awarded vendors taking effect July 1, 2026 under a two-year contract term with optional extensions. Vendors responding to either opportunity must satisfy E-Verify and drug-free workplace requirements, comply with FDA and Drug Supply Chain Security Act (DSCSA) standards, maintain specified insurance coverage including commercial general liability ($5 million for MMCAP), and accept administrative fee structures (3 percent for MMCAP). The code shows limited recent volume — only two identifiable solicitations — and those do not prioritize normethadone explicitly, suggesting this Commodity code may not align closely with active state and local procurement demand.